Viridian Therapeutics, Inc.
VRDN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$34,599 | -$100,735 | -$86,912 | -$79,725 |
| Dep. & Amort. | $110 | $113 | $117 | $123 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $11,250 | $10,844 | $10,220 | $8,975 |
| Change in WC | -$60,328 | $15,865 | -$13,855 | $460 |
| Other Non-Cash | -$1,044 | -$1,460 | -$2,223 | -$3,165 |
| Operating Cash Flow | -$84,611 | -$75,373 | -$92,653 | -$73,332 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$127 | -$42 | -$86 | -$114 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$14,086 | -$55,755 | -$71,243 | -$181,779 |
| Inv. Sales/Matur. | $140,290 | $131,515 | $171,391 | $118,978 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $126,077 | $75,718 | $100,062 | -$62,915 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $9,960 | $1 | $4,943 | $33,646 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $897 | $763 | $4,269 | $1,878 |
| Financing Cash Flow | $10,857 | $764 | $9,212 | $35,524 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $52,323 | $1,109 | $16,621 | -$100,723 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $117,324 | $116,215 | $99,594 | $200,317 |
| End Cash | $169,647 | $117,324 | $116,215 | $99,594 |
| Free Cash Flow | -$84,738 | -$75,415 | -$92,739 | -$73,446 |